Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» obesity
obesity
Arena, The Aftermath
Seeking Alpha
Thu, 04/2/09 - 07:19 am
Arena Pharmaceuticals
obesity
Vivus
Orexigen
Contrave
Qnexa
Arena's Obesity Drug Not Likely to Make It
Seeking Alpha
Tue, 03/31/09 - 12:55 pm
Arena Pharmaceuticals
obesity
Arena Defends Obesity Drug as Stock Plunges
TheStreet.com
Mon, 03/30/09 - 11:06 am
Arena Pharmaceuticals
obesity
Arena reports positive Phase III results for obesity drug
Marketwatch
Mon, 03/30/09 - 08:31 am
Arena Pharmaceuticals
obesity
Arena's Financing Deal with Azimuth Is a Healthy Move
Seeking Alpha
Wed, 03/25/09 - 07:45 am
Arena Pharmaceuticals
obesity
Azimuth
Obesity Drug Arena's Heavy Burden
TheStreet.com
Mon, 03/23/09 - 09:43 am
obesity
Arena Pharmaceuticals
Vivus
fen phen
Orexigen
Wyeth
lorcaserin
GlaxoSmithKline's New Ally For Alli
CNBC
Fri, 03/20/09 - 11:50 am
GSK
Alli
obesity
Arena Pharmaceuticals
Vivus
Three Ways to Play Arena Pharmaceuticals
Seeking Alpha
Wed, 03/18/09 - 08:35 am
Arena Pharmaceuticals
obesity
Vivus
Contrave
Take Advantage of Market Confusion to Buy Orexigen Therapeutics
Seeking Alpha
Tue, 03/17/09 - 09:26 am
obesity
Orexigen
Contrave
Empatic
Eli Lilly
Arena Pharmaceuticals
Vivus
Four Weighty Reasons to Invest in Vivus
Seeking Alpha
Wed, 03/11/09 - 07:51 am
Vivus
Qnexa
obesity
Arena Pharmaceuticals: Near Term Gamble May Be Worth It
Seeking Alpha
Tue, 03/10/09 - 07:36 am
Arena Pharmaceuticals
obesity
Qnexa
Vivus
Orexigen
Contrave
lorcaserin
Vivus: A Bet on Well-Funded, Late-Stage Pipeline 3 comments
Seeking Alpha
Wed, 03/4/09 - 09:19 am
Vivus
pipelines
obesity
Arena Pharmaceuticals
Orexigen
UBS downgrades Arena to 'Neutral' on risk-reward for obesity drug program, shares tumble
Yahoo/AP
Wed, 02/18/09 - 01:36 pm
Arena Pharmaceuticals
obesity
Galapagos shares rally on Merck deal
Marketwatch
Fri, 01/9/09 - 07:01 am
Merck
Galapagos
obesity
diabetes
Orexigen Tanks After-Hours on Obesity Data
TheStreet.com
Thu, 01/8/09 - 05:32 pm
Orexigen
obesity
Contrave
Orexigen to Post Obesity Data in Race With Vivus, Arena
TheStreet.com
Tue, 01/6/09 - 04:51 pm
Orexigen
obesity
Vivus
Arena Pharmaceuticals
Contrave
Qnexa
Arena Seeking a Full BLOOM
Yahoo/Zacks.com
Thu, 12/18/08 - 03:35 pm
Arena Pharmaceuticals
obesity
Wyeth acquires UK firm developing biotech obesity drugs in deal worth up to $150 million
Yahoo/AP
Thu, 12/18/08 - 07:18 am
Wyeth
obesity
buyouts
Thiakis
Slim pickings among obesity drugs
Bizjournals.com
Wed, 12/17/08 - 04:45 pm
obesity
Sanofi
Acomplia
Merck
Januvia
Novo Nordisk
Pages
« first
‹ previous
…
41
42
43
44
45
46
47
48
49